This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako Kyoto

Daniel Simão
Head of the Bayer Pharma Lab at iBET – Instituto de Biologia Experimental e Tecnológica
Speaker

Profile

Daniel Simão is Head of the Bayer Pharma Satellite Lab within the Animal Cell Technology Unit at iBET. He holds a PhD in Bioengineering Systems from the MIT‑Portugal Program and has expertise spanning advanced human cell models, gene therapy vectors, and antibody discovery and characterization. He coordinates a team contributing to industry‑driven R&D projects in biologics, supporting antibody selection, expression platform development, and assay development. His academic research focuses on immune–tissue crosstalk in cardiovascular disease using human iPSC‑derived models.

Agenda Sessions

  • Decoding Macrophage–Fibroblast Crosstalk to Enable Next-Generation Anti-fibrotic Therapies

    14:00